Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
Quidel Corp (NASDAQ: QDEL)
UPDATE: Quidel To Buy Ortho Clinical Diagnostics At $24.68/Share In Cash, Newly-Issued Shares
Transaction Highlights
Brings together highly complementary diagnostic portfolios with world-class technologies and platforms spanning high-throughput systems to near-patient and at-home testing.
Provides
‘New FDA guidance on rapid tests w/Omicron…’ Mentions Abbott BinaxNOW antigen, Quidel QuickVue antigen, Meridian Bioscience Revogene single target test…Applied DNA Sciences Linea’ -Tweet From Nature Reporter
https://twitter.com/amymaxmen/status/1473736804352278538
COVID Testing Kit Makers Respond To Biden’s Call For 500 Million Free At-Home Tests
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to ship free to Americans.
President Biden Tweets ‘Starting this week, the federal government will set up emergency testing sites in areas that need additional testing capacity. Before Christmas, the first several of these federal testing sites will be up and running in New York…
https://twitter.com/POTUS/status/1473402686955479041
‘Web site will be set up next month for any US household wanting to get free #coronavirus tests delivered, says @PressSec.’ -Tweet
Web site will be set up next month for any US household wanting to get free #coronavirus tests delivered, says @PressSec.
New York Attorney General Issues Post ‘Attorney General James Issues Warning to LabQ Diagnostics to Stop Misrepresenting Turnaround Times for COVID-19 Test Results’
https://ag.ny.gov/press-release/2021/attorney-general-james-issues-warning-labq-diagnostics-stop-misrepresenting